Compare Pfizer with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs TTK HEALTHCARE - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER TTK HEALTHCARE PFIZER/
TTK HEALTHCARE
 
P/E (TTM) x 32.7 17.3 189.1% View Chart
P/BV x 5.5 1.4 396.1% View Chart
Dividend Yield % 0.6 1.1 55.7%  

Financials

 PFIZER   TTK HEALTHCARE
EQUITY SHARE DATA
    PFIZER
Mar-18
TTK HEALTHCARE
Mar-19
PFIZER/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs2,3651,215 194.7%   
Low Rs1,625610 266.3%   
Sales per share (Unadj.) Rs430.3444.4 96.8%  
Earnings per share (Unadj.) Rs78.717.2 456.3%  
Cash flow per share (Unadj.) Rs93.227.6 337.3%  
Dividends per share (Unadj.) Rs20.005.00 400.0%  
Dividend yield (eoy) %1.00.5 183.0%  
Book value per share (Unadj.) Rs586.5177.9 329.6%  
Shares outstanding (eoy) m45.7514.13 323.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.62.1 225.8%   
Avg P/E ratio x25.352.9 47.9%  
P/CF ratio (eoy) x21.433.0 64.8%  
Price / Book Value ratio x3.45.1 66.3%  
Dividend payout %25.429.0 87.7%   
Avg Mkt Cap Rs m91,27112,894 707.8%   
No. of employees `0002.62.3 113.8%   
Total wages/salary Rs m3,1431,307 240.5%   
Avg. sales/employee Rs Th7,484.82,715.7 275.6%   
Avg. wages/employee Rs Th1,195.0565.3 211.4%   
Avg. net profit/employee Rs Th1,369.1105.4 1,298.9%   
INCOME DATA
Net Sales Rs m19,6856,279 313.5%  
Other income Rs m1,14378 1,474.7%   
Total revenues Rs m20,8286,356 327.7%   
Gross profit Rs m5,003496 1,009.5%  
Depreciation Rs m663147 451.6%   
Interest Rs m434 12.4%   
Profit before tax Rs m5,479393 1,395.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,878149 1,261.5%   
Profit after tax Rs m3,601244 1,477.5%  
Gross profit margin %25.47.9 322.0%  
Effective tax rate %34.337.9 90.4%   
Net profit margin %18.33.9 471.3%  
BALANCE SHEET DATA
Current assets Rs m24,1672,717 889.4%   
Current liabilities Rs m9,5441,571 607.6%   
Net working cap to sales %74.318.3 406.8%  
Current ratio x2.51.7 146.4%  
Inventory Days Days5532 171.3%  
Debtors Days Days2947 61.5%  
Net fixed assets Rs m9,514991 960.0%   
Share capital Rs m458141 323.8%   
"Free" reserves Rs m26,3752,373 1,111.4%   
Net worth Rs m26,8322,514 1,067.2%   
Long term debt Rs m253 735.3%   
Total assets Rs m36,9004,158 887.4%  
Interest coverage x1,305.512.6 10,348.9%   
Debt to equity ratio x00 68.9%  
Sales to assets ratio x0.51.5 35.3%   
Return on assets %9.86.7 146.4%  
Return on equity %13.49.7 138.5%  
Return on capital %20.416.9 120.6%  
Exports to sales %03.6 0.0%   
Imports to sales %00.5 0.0%   
Exports (fob) Rs mNA225 0.0%   
Imports (cif) Rs mNA31 0.0%   
Fx inflow Rs m22225 9.9%   
Fx outflow Rs m1,48971 2,093.5%   
Net fx Rs m-1,466154 -951.6%   
CASH FLOW
From Operations Rs m3,318173 1,916.8%  
From Investments Rs m-2,38397 -2,469.4%  
From Financial Activity Rs m-1,104-307 359.1%  
Net Cashflow Rs m-169-38 446.9%  

Share Holding

Indian Promoters % 0.0 65.4 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 3.7 202.7%  
FIIs % 4.9 5.2 94.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 25.8 91.9%  
Shareholders   85,207 12,723 669.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   TORRENT PHARMA  ALKEM LABORATORIES  DIVIS LABORATORIES  SANOFI INDIA  ALEMBIC PHARMA  

Compare PFIZER With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views on News

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Oct 18, 2019 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS